Serum Visfatin/eNAMPT as a Biomarker in Pancreatic and Small Intestine Neuroendocrine Tumors: A Cross-Sectional Study and Future Perspectives. The gene discussed is NAMPT; the disease is small intestine neuroendocrine neoplasm.